Company Overview

Generex Biotechnology Corporation engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company’s primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Glucose RapidSpray that delivers glucose through a pump spray to the mouth, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the ...

read more


As of 07:18PM EDT July 30, 2014
$ 0.021   -0 (-1.87%)
Today's Open: 0.0205 Previous Close: 0.0214
Today's High: 0.0214 Volume: 593,431
Today's Low: 0.0205 Avg Vol: 1,611,507
52 Week High: 0.056 Bid (size): 0
52 Week Low: 0.02 Ask (size): 0


To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 555 Richmond Street West, Suite 604, Toronto, ON M5V 3B1, Canada
Mailing Address: -
Phone: 416-364-2551
Fax: 647-547-7104
Website: http//

Company Details:

Symbol: GNBT
SIC: -
State location: A1
Sector: -
State of Inc: DE
Employees: 43
Type: -

Key executives:

Name Age Position
Anna E. Gluskin 63 Chairman, Chief Exec. Officer and Pres
Eric Von Hofe Ph.D. 2014 Pres of Antigen Express
Gerald Bernstein M.D. 81 VP of Medical Affairs
Mark Fletcher Esq. 48 Exec. VP and Gen. Counsel
Rose C. Perri 47 Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer


Generex Biotechnology Corp. (OTCMKTS:GNBT) With A Strong Start Of 2014 January 13, 2014

After fluctuating around $0.03 for the past four months the stock of Generex Biotechnology Corp. (OTCMKTS:GNBT) was finally able to break out. The start of the new year has brought a fresh dose of optimism and the ticker has been on a constant climb mak... read more

Generex Biotechnology Corporation (OTCMKTS:GNBT) Comes Under the Spotlight Once Again January 7, 2014

Positive PR around Generex Biotechnology Corporation (OTCMKTS:GNBT) has been plentiful over the last couple of months. The company is now focused on getting the AE37 breast cancer vaccine on the market and if the announcements are to be believed, things... read more

Generex Biotechnology Corp. (OTCMKTS:GNBT) Continues Upwards July 4, 2013

The fact that yesterday's market was cut in half did not stop the stock of Generex Biotechnology Corp. (OTCMKTS:GNBT) of having the best session for over a month. It added 12% to its value and for a brief moment in early trading touched upon $0.5 but su... read more

Generex Biotechnology Corp.(OTCMKTS:GNBT) On Its Way To Recovery June 3, 2013

After the slump they suffered back on May 24 Generex Biotechnology Corp. (OTCMKTS:GNBT) finally recovered some of the lost ground. A couple of tumultuous sessions followed after the fall to 3 cents per share. Finally last Friday the ticker recovered som... read more


New product tease rewards TEGY traders with a 45% gain Dec 16, 2010, 15:52

    New product tease rewards TEGY traders with a 45% gain     TEGY Adds Some New Power Technologies to its Platform, and the Market Applauds! Good Afternoon! We knew that Transact Energy Corp. (TEGY) tends to make large and sudden moves, but this morning's 45% bounce was a lot more satisfying than we expected! After TEGY announced that it's talking about licensing read more

Promoter: Paying Party: Unknown Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: $50,000 Avg $ Volume for Period: UNKNOWN

=?WINDOWS-1252?Q?GNBT_is_being_accumulated_ Dec 16, 2010, 09:41

      GNBT is being accumulated – FAST!   Trade Alert: Generex Biotechnology Corp. (GNBT)   GNBT is 83% Off Recent Highs – But Now Reversing Course as FDA Approval is Sought!   Good Morning Hideout Trader!   The future of Generex Biotechnology Corporation (GNBT) which develops drug delivery systems and technologies is looking mighty bright again!   The read more

Promoter: Stock Hideout Paying Party: Unknown Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: $90,000 BlueWave Advisors, LLC owns seventy five percent of the outstanding membership interests of StockHideout LLC. Stock_Analyzer owns twenty five percent of the outstanding membership interests of StockHideout, LLC. BlueWave Advisors has been compensated ninety thousand dollars from Emerging Equity Advisors, Inc. - non-controlling 3rd party sh Avg $ Volume for Period: UNKNOWN

PennyStockProphet - GNBT - Thursday! Dec 16, 2010, 09:20

PSP Members, I've got a bio-tech pick for us today that's picking up enormous momentum as it appears ready to bounce of it's 52-week low! This is a NASDAQ quality company currently trading at penny stock prices, and it's time to take advantage of it! The company's current 10-day trading average is over 1.3 Million shares per day and climbing! Volume has been picking up every day since Monday, and the company just announced yesterday a new patent read more

Promoter: Penny Stock Prophet Paying Party: UNKNOWN Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

Generex Biotech (GNBT) MESSAGE BOARD

Post # Subject Re Name Date
1 Think, that GNBT is about to go up and green. 0
2 Have you seen this video on the... 0
3 I though that here on the message board of... 2
4 reverse splits never work, they only... 0
5 Ilike this stock for several reasons. I... 1
6 Hi Anna E Gluskin1. Why are desperate in... 0
7 At the moment, the stock has changed its... 0
8 Here on this message board we are inviting... 0